Primary Site >> Colorectal Cancer
Gene >> DSC3
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Desmocollin switching in colorectal cancer. PMID: 17088906 |
Ref: Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer. PMID: 20201417 |
Ref: Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer. PMID: 20535630 Ref: Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. PMID: 21103076 |
Ref: DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer. PMID: 21364582 Ref: Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. PMID: 21400501 Ref: Development of novel combined time and pH-dependent based drug delivery systems for targeting 5-fluorouracil to the colon. PMID: 21696357 Ref: Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique. PMID: 21702702 |
Ref: Soluplus--solubilized citrated camptothecin--a potential drug delivery strategy in colon cancer. PMID: 22105472 Ref: ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. PMID: 22213796 Ref: Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma. PMID: 22438068 |
Ref: A novel polyrotaxane-based delivery system for scutellarin: preparation, characterization, and in vitro evaluation. PMID: 24036381 |
Ref: Host-guest inclusion system of scutellarein with 2-hydroxypropyl-beta-cyclodextrin: preparation, characterization, and anticancer activity. PMID: 24555409 Ref: Three levels face centered central composite design of colon targeted micro-particulates system of celecoxib: screening of formulations variables and in vivo studies. PMID: 24844925 Ref: Inclusion complex of GA-13316 with beta-cyclodextrin: preparation, characterization, molecular modeling, and in vitro evaluation. PMID: 25037400 |
Ref: Preparation and cytotoxicity of N,N,N-trimethyl chitosan/alginate beads containing gold nanoparticles. PMID: 25159881 Ref: Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer. PMID: 25478964 Ref: Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines. PMID: 25929336 Ref: Synthesis, characterization and in vitro evaluation of a series of novel polyrotaxane-based delivery system for artesunate. PMID: 25988495 Ref: Expression changes of cell-cell adhesion-related genes in colorectal tumors. PMID: 26137091 |
Ref: Development and characterization of pH responsive polymeric nanoparticles of SN-38 for colon cancer. PMID: 26540095 Ref: Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis. PMID: 27397719 |
Ref: Hydrophilic drug encapsulation in shell-core microcarriers by two stage polyelectrolyte complexation method. PMID: 28034735 Ref: Deep Learning for Fully-Automated Localization and Segmentation of Rectal Cancer on Multiparametric MR. PMID: 28706185 Ref: Thiol-ene miniemulsion polymerization of a biobased monomer for biomedical applications. PMID: 28843199 |
Ref: Facile development, characterization, and optimization of new metformin-loaded nanocarrier system for efficient colon cancer adjunct therapy. PMID: 29429370 Ref: Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation. PMID: 29493289 Ref: Technical Note: A deep learning-based autosegmentation of rectal tumors in MR images. PMID: 29663417 Ref: Development of biopolymers based interpenetrating polymeric network of capecitabine: A drug delivery vehicle to extend the release of the model drug. PMID: 29705110 Ref: Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy. PMID: 30248424 |